Important Safety Information  •  Patient Info  •  Prescribing Info     Consumer Information






Privacy Policy - Your Privacy Rights

Graceway Pharmaceuticals, LLC ("Graceway") is committed to respecting your privacy rights. Please read the following policy to understand how your personal information will be treated. This policy may change from time to time, so please check back periodically. The use of information that we gather now is subject to the privacy notice in effect at the time of use. This policy will let you know the following:

  1. What information is collected from me?
    Graceway collects and stores the following types of information from users of our Website: (i) information you voluntarily enter on our Website or give us in any other way, including, but not limited to, "personally identifiable information" such as your name, address, e-mail address, phone number and facsimile number; (ii) information we receive from you via e-mail communications information; (iii) information we collect from you through the use of "cookies" (see paragraph 2 below); and (iv) other information that we collect automatically. Examples of information that we collect and analyze automatically include the Internet protocol (IP) address used to connect your computer to the Internet, computer and connection information such as browser type and version, operating system, and platform, the full Uniform Resource Locators (URL) clickstream to, through, and from our Website, including the date and time, the cookie number, products you viewed or searched for, and the phone number used to call any Graceway toll-free telephone number.
  2. What are cookies and how are they used?
    Graceway may place Internet cookies on your hard drive. Cookies are small files that may be downloaded to your hard disk for record-keeping purposes. Among other things, cookies are used to: (i) remind us of who you are in order to deliver better service; (ii) estimate our audience size by determining repeat usage of our Website to help target advertisements based on user interests and behavior; (iii) track your progress and entries in promotions, sweepstakes and contests, if any; and (iv) measure certain traffic patterns for use as a research tool to understand how our users' habits are similar or different from one another. You can set your browser to notify you when you receive a cookie, giving you the chance to decide whether or not to accept it. By not accepting cookies, some Web pages may not display properly or you may not be permitted to access certain information. Transparent GIFs: We, and/or our agents, may use GIFs, or pixel tags on our Website. These GIFs allow recognition of a browser's cookie when a browser visits this website. We track information provided to us by your browser, including the Website you came from (known as the referring URL), your IP address, domain name, the type of browser you use, the time and date of access, and other information that does not personally identify you (e.g., your name, address, e-mail address, phone number).
  3. How is my information used?
    The personally identifiable information you provide will be used to support your customer relationship with Graceway. Unless you have chosen to "opt-out" by notifying Graceway at webadmin@Gracewaypharm.com, Graceway may sell, rent, or lease your personally identifiable information to, or share your personally identifiable information with, third parties. Your personally identifiable information may be shared with our agents, contractors or business partners in order that they may perform services for Graceway, regardless of whether or not you have chosen to "opt-out" as set forth above. We want to help you quickly find information on Graceway and alert you to specific offers, updated information, and other new products and services from Graceway. Accordingly, we may send you direct mailings or contact you by telephone about our various products and services or other products and services we feel may be of interest to you. You may choose not to receive such mailings or telephone calls by the means provided for in the mailings or by contacting us at webadmin@Gracewaypharm.com. Graceway does research on our users' demographics, interests and behavior based on the information provided to us during your use of our Website. This research is compiled and analyzed on an aggregated basis. Aggregated data does not include personally identifiable information. Graceway may share this aggregated data with others. We will release your personally identifiable information when we believe that such release is appropriate to (i) comply with the law; (ii) enforce or apply our Terms of Use and other agreements; or (iii) protect the rights, property or safety of Graceway, our users or others. This includes, but is not limited to, exchanging information with other companies and organizations for fraud protection and credit risk protection. Also, as we continue to develop our business, we might sell or buy stores or assets. In such transactions, customer information generally is one of the transferred business assets. Also, in the unlikely event that Graceway, or substantially all of its assets are acquired, customer information will of course be one of the transferred assets. Please be aware that Graceway advertisers or Websites that have links on our site may collect personally identifiable information from you. The information practices of those Websites linked to Graceway either through advertisements or other hyperlinks are not covered by this privacy statement.
  4. How can I access, update or delete my information?
    Currently, we do not offer you the opportunity to directly access, update, or delete information collected about you. In the future, we may provide you with a process to do so. You can request certain individual information that Graceway has collected about you by contacting Graceway at webadmin@Gracewaypharm.com.
  5. What else should I know about my privacy?
    Third party Internet sites and services accessible through Graceway have separate privacy and data collection practices, independent of us. Graceway has no responsibility or liability for these independent policies or actions. Please be careful and responsible online. If you post personal information online that is accessible to the public, you may receive unsolicited messages from other parties in return. While we strive to protect your information, Graceway does not ensure or warrant the security of any information through the transmission process, and you transmit information to Graceway at your own risk.
  6. What about my children and their use of your Website?
    Children should always ask a parent for permission before sending personal information to anyone online. Graceway encourages parents to take an active role in their children's use of the Internet and to spend time online with their children. Graceway will use its best efforts not to collect personal information for those identifying themselves as age 17 or under.
  7. Other Legal Notices.
    Any dispute over privacy is subject to this privacy policy and our Terms of Use, including limitations on damages and application of the law of the state of Tennessee. If you have any concern about your privacy in connection with this policy, please send us a thorough description to webadmin@Gracewaypharm.com, and we will try to resolve it. We may post a revised privacy policy on our site. Please note that the use of information that we gather is subject to the privacy notice in effect at the time of use. You should check our Website frequently to see recent changes.
Graceway Pharmaceuticals           Privacy Policy           Terms of Use




ESTRASORB is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause. Estrasorb should not be used in women with any of the following conditions: undiagnosed abnormal genital bleeding; known, suspected, or history of cancer of the breast; known or suspected estrogen-dependent neoplasia; active deep-vein thrombosis, pulmonary embolism or history of these conditions; active or recent (eg, within the past year) arterial thromboembolic disease (eg, stroke, myocardial infarction); liver dysfunction or disease. ESTRASORB should not be used in patients with known hypersensitivity to its ingredients; known or suspected pregnancy. There is no indication for ESTRASORB in pregnancy. There appears to be little or no increased risk of birth defects in women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy (see PRECAUTIONS in full Prescribing Information).

Estrogens increase the risk of endometrial cancer. Close clinical surveillance of all women taking estrogen is important. Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. There is no evidence that the use of "natural" estrogens results in a different endometrial risk profile than synthetic estrogens at equivalent estrogenic doses. (see WARNINGS, Malignant neoplasms, Endometrial cancer).
Cardiovascular and other risks. Estrogens with or without progestins should not be used for the prevention of cardiovascular disease or dementia. (see WARNINGS, Cardiovascular disorders and Dementia).
The Women's Health Initiative (WHI) study reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50 to 79 years of age) during 5 years of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone acetate (MPA 2.5 mg) relative to placebo (see CLINICAL PHARMACOLOGY, Clinical Studies, Warnings, Cardiovascular disorders and Malignant neoplasms, Breast cancer).
The Women's Health Initiative Memory Study (WHIMS), a substudy of WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with oral conjugated estrogens plus medroxyprogesterone acetate relative to placebo.

It is unknown whether or not this finding applies to younger postmenopausal women. (See CLINICAL PHARMACOLOGY, Clinical Studies, Warnings, Dementia and PRECAUTIONS, Geriatric Use). Other doses of conjugated estrogens with medroxyprogesterone acetate, and other combinations of estrogens and progestins were not studied in the WHI and, in the absence of comparable data, these risks should be assumed to be similar. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.